Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.50 |
| ▸ | CA2 | P00918 | 4/20 | 0.50 |
| ▸ | CA7 | P43166 | 3/20 | 0.50 |
| ▸ | CA9 | Q16790 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.48 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29387155 | 1.00 | CA1 (0.50) | CA1CA2CA7CA9CA12 | |
| SCHEMBL27678814 | 0.88 | SMN1; SMN2 (0.42) | CA1CA2CA7CA9CA12 | |
| Anisole SCHEMBL27752808 | 0.88 | CA4 (0.54) | CA1CA2CA7CA9CA12 | |
| SCHEMBL630768 | 0.87 | CA1 (0.58) | CA1CA2CA7CA9CA12 | |
| SCHEMBL27341088 | 0.81 | TOP1 (0.47) | CA1CA2CA7CA9CA12 | |
| SCHEMBL27717938 | 0.81 | ALDH1A1 (0.48) | CA1CA2CA7CA9CA12 | |
| SCHEMBL29466747 | 0.79 | — | — | |
| SCHEMBL22390 | 0.79 | — | — | |
| SCHEMBL8966569 | 0.79 | SLC6A2 (0.50) | NFE2L2L3MBTL1TDP1SLC6A2SLC6A4 | |
| SCHEMBL27859496 | 0.79 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4712192-A1 | ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING SAME | Central Glass Co., Ltd. (JP) | 2026-03-18 | — | — | EP | claimed |
| US-20260005312-A1 | NON-AQUEOUS ELECTROLYTE CONTAINING TIN SALT OR GERMANIUM SALT AND SECONDARY BATTERY EMPLOYING SAME | DAEGU GYEONGBUK INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2026-01-01 | — | — | US | claimed |
| EP-4131553-B1 | PRODUCTION METHOD FOR SOLID-STATE BATTERY, AND SOLID-STATE BATTERY | TERAWATT TECH K K (JP) | 2025-04-23 | — | — | EP | claimed |
| WO-2025070769-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | セントラル硝子株式会社 | 2025-04-03 | — | — | WO | claimed |
| WO-2025070770-A1 | COMPOUND HAVING OXAZOLIDINE STRUCTURE, NONAQUEOUS ELECTROLYTE CONTAINING SAID COMPOUND, AND NONAQUEOUS ELECTROLYTE BATTERY CONTAINING SAID NONAQUEOUS ELECTROLYTE | セントラル硝子株式会社 | 2025-04-03 | — | — | WO | claimed |
| US-20250105353-A1 | Electrolyte Solution for Nonaqueous Electrolyte Batteries, and Nonaqueous Electrolyte Battery Using Same | CENTRAL GLASS COOMPANY, LIMITED (JP) | 2025-03-27 | — | — | US | claimed |
| US-12199241-B2 | Electrolyte solution for nonaqueous electrolyte batteries, and nonaqueous electrolyte battery using same | CENTRAL GLASS COMPANY, LIMITED (JP) | 2025-01-14 | — | — | US | claimed |
| WO-2024253162-A1 | ELECTROLYTE SOLUTION FOR NONAQUEOUS ELECTROLYTE SECONDARY BATTERY, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY CONTAINING SAME | セントラル硝子株式会社 | 2024-12-12 | — | — | WO | claimed |
| CN-118983520-A | Preparation of lithium iron manganese phosphate battery electrolyte | 安徽得壹能源科技有限公司 | 2024-11-19 | — | — | CN | claimed |
| CN-118084632-A | Preparation and purification process of 2, 3-difluoroanisole | 江西正梦新材料有限公司 | 2024-05-28 | — | — | CN | claimed |
| CN-1317842-A | Method for manufacturing battery | SONY CORP (JP) | 2001-10-17 | — | — | CN | claimed |
| CN-1316786-A | Manufacturing method of battery | SONY CORP (JP) | 2001-10-10 | — | — | CN | claimed |
| CN-1293461-A | Gel electrolyte and gel electrolyte battery | SONY CORP (JP) | 2001-05-02 | — | — | CN | claimed |
| WO-2001029920-A1 | SHUTDOWN AND REDOX SHUTTLE ADDITIVES FOR BATTERIES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2001-04-26 | — | — | WO | claimed |
| EP-1089371-A1 | Gel electrolyte and gel electrolyte cell | SONY CORPORATION (JP) | 2001-04-04 | — | — | EP | claimed |
| CN-1275816-A | Solid electrolytic battery | SONY CORP (JP) | 2000-12-06 | — | — | CN | claimed |
| CN-1267926-A | Gel electrolyte and gel electrolytic cell | SONY CO LTD (JP) | 2000-09-27 | — | — | CN | claimed |
| CN-1190093-A | Synthesis of 4-methoxyl polyfluorophenyl nitrile | SHANGHAI INST ORGANIC CHEM (CN) | 1998-08-12 | — | — | CN | claimed |
| WO-1995015301-A1 | PREPARATION OF 4,4'-DIHYDROXY-ALPHA-ALKYLSTILBENES AND 4,4'-DIHYDROXY-ALPHA, ALPHA'-DIALKYLSTILBENES | THE DOW CHEMICAL COMPANY (US) | 1995-06-08 | — | — | WO | claimed |
| EP-0488861-A1 | Process for the preparation of alkoxylated aromatic compounds | RHONE-POULENC CHIMIE (FR) | 1992-06-03 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260005312-A1 | NON-AQUEOUS ELECTROLYTE CONTAINING TIN SALT OR GERMANIUM SALT AND SECONDARY BATTERY EMPLOYING SAME | KCNN4, SCN2B, KAT2B | CA1 166/4885CA2 100/4885CA7 60/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.